Siemens Receives CE Mark for Whole-Body Molecular MR System

Siemens HealthcareSiemens Healthcare announced CE marking for its Biograph mMR system. The CE marking states that the product is assessed before being placed on the market and meets EU safety, clinical benefit and environmental protection requirements. Customers can begin using the new system in Europe for clinical routine application. Biograph mMR is the world's only fully integrated whole-body molecular MR with simultaneous MR and PET data acquisition technology.

Biograph mMR comprises a 3-Tesla magnetic resonance (MR) scanner and an integrated positron emission tomography (PET) detection system with an architecture that performs as one and was designed for uncompromised MR and PET image quality. While MR provides exquisite morphological and functional details in human tissue, PET goes further to investigate at the same time the human body at the level of cellular activity and metabolism. With its simultaneous data acquisition, the innovative system is expected to prove to be particularly valuable in the identification of neurological, oncological and cardiac conditions of disease and in supporting therapy planning. The Biograph mMR also opens new opportunities for research, such as the development of new biomarkers or new therapeutic approaches. Siemens has already installed a number of Biograph mMR systems at customer sites for clinical research, including university hospital Klinikum rechts der Isar of the Munich Technical University, the university hospital of the Eberhard Karls University Tuebingen in Germany, and Massachusetts General Hospital in Boston, USA.

Related news articles:

About Siemens Healthcare
The Siemens Healthcare Sector is one of the world's largest healthcare solution providers and a leading manufacturer and service provider in the fields of medical imaging, laboratory diagnostics, hospital information technology and hearing instruments. It offers solutions covering the entire supply chain under one roof - from prevention and early detection to diagnosis and on to treatment and aftercare. By optimizing clinical workflows oriented toward the most important clinical pictures, Siemens also strives to make healthcare faster, better and, at the same time, less expensive. Siemens Healthcare currently has some 48,000 employees worldwide and is present throughout the world. During fiscal 2010 (up to September 30) the Sector posted sales worth 12.4 billion euros and profits of around 750 million euros.

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...